US$246 million fund for consumer, biotechnology, agrotechnology
Mekong Enterprise Fund IV (MEF IV) was launched in 2019 with US$246 million in committed capital, more than double its predecessor, Mekong Enterprise Fund III.
MEF IV continues Mekong Capital’s successful strategy of investing in growth equity investments in Vietnamese companies in proven consumer-driven sectors that benefit from the growth in Vietnamese consumer demand and the rise of the middle class. The Fund also added healthcare, biotechnology and agrotechnology as core focus areas.